|
Post by shortslaver on Jan 27, 2015 14:22:07 GMT -5
I think we had this conversation recently and I think the consensus was that people who use a diabetes message board are people that derive a lot of identity from their disease. They likely have rituals around setting up their dosing and their habits learned from all these years. Something that is different to them is something that is scary.
|
|
|
Post by joeypotsandpans on Jan 27, 2015 14:41:15 GMT -5
I think we had this conversation recently and I think the consensus was that people who use a diabetes message board are people that derive a lot of identity from their disease. They likely have rituals around setting up their dosing and their habits learned from all these years. Something that is different to them is something that is scary. My theme for the day....one of the top reasons for business failure is resistance to change, change is very scary for some....kind of like giving up on your blackberry after so many years and giving into advances in tech (inside joke)...even though you still think some of the old way was better. In the case of a renaissance change/paradigm shift in the way to treat Diabetes you can just imagine how some who have been afflicted and set in their ways for a lifetime may perceive it, they will overcome their fears only by learning from those peers around them.
|
|
|
Post by gomnkd on Jan 27, 2015 14:53:18 GMT -5
There are these so called influencers (Malcolm Gladwell's book talk about this). These influencers should first try out Afrezza and sing its praises. Once they do it, the other would follow suit. We may see this dynamic happen soon.
The only person who likes change is a baby with a soiled diaper.
|
|
|
Post by sam221 on Jan 27, 2015 15:14:38 GMT -5
Most of the diabetes community websites I have searched for Afrezza almost always had some downbeat comments from hyper active members of those respective communities. But then I came across a candid confession on one of those boards that makes sense. Basically the commenters/authors that post on these diabetes websites are Type A personalities who have worked very hard (physically as well as mentally) to control their diabetes & are proud to show off – but with Afrezza they see a threat & democratization of diabetes control (just with so much ease & comfort).
|
|
|
Post by alcc on Jan 27, 2015 16:41:08 GMT -5
What I am trying to say is that most people who get and stay on forums are the ones that need to justify whatever it is that they are doing. Gulp... D'OH!! Self-awareness is important -- and rare these days!
|
|
|
Post by dreamboatcruise on Jan 27, 2015 17:36:04 GMT -5
Final comment on that particular thread on diabetesforum.com, one of the moderators (not the same as any of the previous posters) closed the thread with...
This thread is going nowhere. We are aware of the arrival of a new version of insulin. Our confidence in it is limited and we do consider the side effects significant. The side effects of other drugs have no bearing on that fact.
This thread is now closed.
So, whatever the reason, I guess we won't be seeing much praise of Afrezza in that particular forum anytime soon.
|
|
|
Post by suebeeee1 on Jan 27, 2015 17:37:16 GMT -5
Of course you're exempt from said statement! Darn straight! This is a SOLUTIONS board, not a whinning one...lol!
|
|
|
Post by dreamboatcruise on Jan 27, 2015 17:41:21 GMT -5
Of course you're exempt from said statement! Darn straight! This is a SOLUTIONS board, not a whinning one...lol! And it's ok to have strong opinions when you're right. Someone please pass another cup of kool aid
|
|
Deleted
Deleted Member
Posts: 0
|
Post by Deleted on Jan 27, 2015 21:18:54 GMT -5
Final comment on that particular thread on diabetesforum.com, one of the moderators (not the same as any of the previous posters) closed the thread with... This thread is going nowhere. We are aware of the arrival of a new version of insulin. Our confidence in it is limited and we do consider the side effects significant. The side effects of other drugs have no bearing on that fact.This thread is now closed.So, whatever the reason, I guess we won't be seeing much praise of Afrezza in that particular forum anytime soon. Lol wow. Guess you know where the mods stand.
|
|
|
Post by BlueCat on Jan 27, 2015 23:35:09 GMT -5
The only person who likes change is a baby with a soiled diaper. And even they resist sometimes.
|
|
|
Post by mannmade on Jan 27, 2015 23:35:52 GMT -5
Well here's an encouraging story that I personally experienced... I am well acquainted with one of the top diabetes care specialists (GP/MD) in Southern California. In fact he was consulted on Lantus by Sanofi and has been part of their trend/influencer groups before. I had lunch with him two months ago or so to pick his brain on Afrezza. During our lunch he gave me almost verbatim what I would call "the Short's thesis" on non adoption by patients with diabetes eg; needles so thin not a big deal, pens are convenient, lots of great options for treatment, no one will want to switch, etc and while he agreed that the fast in/fast out was compelling he did not think it would be compelling enough for people to switch or change the current paradigm when there could possibly be lung issues, etc...
Cut to today, I got an email from him and he told me he just had a meeting with his Sanofi rep to detail Afrezza. His words were "it looks pretty cool and easy to use." have not followed up yet but looks like he may be recommending Afrezza.
My take aways from this are the following:
1.) The Sanofi reps are indeed on the street meeting with key doctors and not wasting any time
2.) The Sanofi reps are well trained and professional group
3.) The sell for the skeptical doctors may be easier than many presumed
I know this is just anecdotal information but I know it is factual and may bode well for us longs...
|
|
|
Post by Chris-C on Jan 28, 2015 11:28:02 GMT -5
Well here's an encouraging story that I personally experienced... I am well acquainted with one of the top diabetes care specialists (GP/MD) in Southern California. In fact he was consulted on Lantus by Sanofi and has been part of their trend/influencer groups before. I had lunch with him two months ago or so to pick his brain on Afrezza. During our lunch he gave me almost verbatim what I would call "the Short's thesis" on non adoption by patients with diabetes eg; needles so thin not a big deal, pens are convenient, lots of great options for treatment, no one will want to switch, etc and while he agreed that the fast in/fast out was compelling he did not think it would be compelling enough for people to switch or change the current paradigm when there could possibly be lung issues, etc... Cut to today, I got an email from him and he told me he just had a meeting with his Sanofi rep to detail Afrezza. His words were "it looks pretty cool and easy to use." have not followed up yet but looks like he may be recommending Afrezza. My take aways from this are the following: 1.) The Sanofi reps are indeed on the street meeting with key doctors and not wasting any time 2.) The Sanofi reps are well trained and professional group 3.) The sell for the skeptical doctors may be easier than many presumed I know this is just anecdotal information but I know it is factual and may bode well for us longs... MannMade. Thanks for posting this. I think it illustrates well the typical process for spreading the word. It takes individual contacts, experience and time. Although a professional network of physician prescribers is different than a patient network of diabetics, the same principles are at play. Some posters (including myself) have made reference to Malcolm Gladwell's influential book "The Tipping Point". Many posters have noted that change is difficult, that habits and routines are hard to change (we should all be able to attest to this personally with one example or another). For those unfamiliar with the book, there is a useful summary here Tipping Point WikiSummary. Gladwell makes several important points in his book, not the least of which is that tipping points are reached by lots of small connections with individuals— and over time these can lead to contagion or the point of critical mass where the idea really catches hold. The speed and success in changing minds depends on the individuals involved (since not all people in a network have the same degree of influence). But Gladwell also makes a point about how change is influenced by emotions more than facts and that great ideas have a stickiness factor. He notes that the stickiness of an idea is related to how it solves a problem with a convenient amount of effort and time and at an affordable cost. I've long believed that the convenience of the dreamboat inhaler may be a key point in its success. Based on what you wrote, seeing the inhaler and ease of use seemed to open your friend's mind. Maybe Gladwell was right. Care seems also to have been taken to price Afrezza in a competitively affordable manner. I'm not sure if Sanofi plans to market this through direct to consumer ads, but I think there have been posts that support this (someone posted a notice awhile back where an actor was sought for such an advertisement). I can almost guarantee that SNY's marketing people will emphasize the convenience and social acceptability of this alternative to injections because those are stickiness factors. GLTA Chris_C
|
|
|
Post by 1 percenter on Jan 28, 2015 12:43:27 GMT -5
I went into three pharmacies yesterday. One was a Rite Aid and the pharmacist was not aware of Afrezza but I had her check her computer and sure enough it was there. She told me that she didn't know if her distributor had it but she could find out. I told her no need to but it is showing up at Rite Aid. I also went into two smaller pharmacies located in medical buildings. Neither pharmacist heard about it but one did check her system and came back that she could order it with an RX. So there is no doubt that it's out there even though it hasn't officially been launched, as far as we know.
|
|
|
Post by joeypotsandpans on Jan 28, 2015 12:46:30 GMT -5
Well here's an encouraging story that I personally experienced... I am well acquainted with one of the top diabetes care specialists (GP/MD) in Southern California. In fact he was consulted on Lantus by Sanofi and has been part of their trend/influencer groups before. I had lunch with him two months ago or so to pick his brain on Afrezza. During our lunch he gave me almost verbatim what I would call "the Short's thesis" on non adoption by patients with diabetes eg; needles so thin not a big deal, pens are convenient, lots of great options for treatment, no one will want to switch, etc and while he agreed that the fast in/fast out was compelling he did not think it would be compelling enough for people to switch or change the current paradigm when there could possibly be lung issues, etc... Cut to today, I got an email from him and he told me he just had a meeting with his Sanofi rep to detail Afrezza. His words were "it looks pretty cool and easy to use." have not followed up yet but looks like he may be recommending Afrezza. My take aways from this are the following: 1.) The Sanofi reps are indeed on the street meeting with key doctors and not wasting any time 2.) The Sanofi reps are well trained and professional group 3.) The sell for the skeptical doctors may be easier than many presumed I know this is just anecdotal information but I know it is factual and may bode well for us longs... MannMade. Thanks for posting this. I think it illustrates well the typical process for spreading the word. It takes individual contacts, experience and time. Although a professional network of physician prescribers is different than a patient network of diabetics, the same principles are at play. Some posters (including myself) have made reference to Malcolm Gladwell's influential book "The Tipping Point". Many posters have noted that change is difficult, that habits and routines are hard to change (we should all be able to attest to this personally with one example or another). For those unfamiliar with the book, there is a useful summary here Tipping Point WikiSummary. Gladwell makes several important points in his book, not the least of which is that tipping points are reached by lots of small connections with individuals— and over time these can lead to contagion or the point of critical mass where the idea really catches hold. The speed and success in changing minds depends on the individuals involved (since not all people in a network have the same degree of influence). But Gladwell also makes a point about how change is influenced by emotions more than facts and that great ideas have a stickiness factor. He notes that the stickiness of an idea is related to how it solves a problem with a convenient amount of effort and time and at an affordable cost. I've long believed that the convenience of the dreamboat inhaler may be a key point in its success. Based on what you wrote, seeing the inhaler and ease of use seemed to open your friend's mind. Maybe Gladwell was right. Care seems also to have been taken to price Afrezza in a competitively affordable manner. I'm not sure if Sanofi plans to market this through direct to consumer ads, but I think there have been posts that support this (someone posted a notice awhile back where an actor was sought for such an advertisement). I can almost guarantee that SNY's marketing people will emphasize the convenience and social acceptability of this alternative to injections because those are stickiness factors. GLTA Chris_C Tipping point....one needs only to look at Netflix vs. Blockbuster Video, I have brought this example up in the past while mentioning when Whitney Tilson from T2 a very savvy and widely respected person on the street was stubbornly short NFLX and reversed course after some hefty losses.... years ago when I got pissed off at blockbuster for what was an erroneous late fee I finally took notice of the little red square advertisement and said why not, I had asked several people if they had used them and no one had at the time and they really didn't pay much heed to it....NFLX was trading around $9 if I recall...well I tried them and never looked back, as far as the stock it had moved up to the 12-15 area and I waited for the pullback that never came...well you know the rest. Point is the the tipping point didn't take long once the momentum of word of mouth took place...believe the same holds true within the next 3-9 mos. in the Diabetic world.
|
|
|
Post by babaoriley on Jan 28, 2015 13:09:38 GMT -5
I went into three pharmacies yesterday. One was a Rite Aid and the pharmacist was not aware of Afrezza but I had her check her computer and sure enough it was there. She told me that she didn't know if her distributor had it but she could find out. I told her no need to but it is showing up at Rite Aid. I also went into two smaller pharmacies located in medical buildings. Neither pharmacist heard about it but one did check her system and came back that she could order it with an RX. So there is no doubt that it's out there even though it hasn't officially been launched, as far as we know. Good to see many people in the business haven't even heard of it yet, more potential investors and investment networks!
|
|